INGREZZA

Pharmaceutical preparations for human use for schizophrenia, adjunctive treatment of schizophrenia, schizoaffective disorder, bipolar disorder, bipolar mania, DiGeorge syndrome, Lesch-Nyhan syndrome, and movement disorders, namely, Myoclonus, chorea associated with Huntington's Disease, Levodopa-induced dyskinesia, dyskinetic cerebral palsy, dystonia, and tics; Pharmaceutical preparations for the treatment of neurological, central nervous system, and movement diseases and disorders